FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
Progenics Pharma (NASDAQ: PGNX) reported Q4 EPS of ($0.18), $0.05 worse than the analyst estimate of ($0.13).
For earnings history and earnings-related data on Progenics Pharma (PGNX) click here.
... More
